spacer
spacer

PDBsum entry 2vaf

Go to PDB code: 
protein links
Metal binding protein PDB id
2vaf

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
349 a.a. *
* Residue conservation analysis
PDB id:
2vaf
Name: Metal binding protein
Title: Crystal structure of human cardiac calsequestrin
Structure: Calsequestrin-2. Chain: a. Fragment: residues 22-399. Synonym: calsequestrin, cardiac muscle isoform, human cardiac calsequestrin. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Organ: heart. Expressed in: escherichia coli. Expression_system_taxid: 469008.
Resolution:
3.80Å     R-factor:   0.274     R-free:   0.325
Authors: E.Kim,B.Youn,L.Kemper,C.Campbell,H.Milting,M.Varsanyi,C.Kang
Key ref:
E.Kim et al. (2007). Characterization of human cardiac calsequestrin and its deleterious mutants. J Mol Biol, 373, 1047-1057. PubMed id: 17881003 DOI: 10.1016/j.jmb.2007.08.055
Date:
31-Aug-07     Release date:   11-Sep-07    
Supersedes: 2v0q
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
O14958  (CASQ2_HUMAN) -  Calsequestrin-2 from Homo sapiens
Seq:
Struc:
399 a.a.
349 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 

 
DOI no: 10.1016/j.jmb.2007.08.055 J Mol Biol 373:1047-1057 (2007)
PubMed id: 17881003  
 
 
Characterization of human cardiac calsequestrin and its deleterious mutants.
E.Kim, B.Youn, L.Kemper, C.Campbell, H.Milting, M.Varsanyi, C.Kang.
 
  ABSTRACT  
 
Mutations of conserved residues of human cardiac calsequestrin (hCSQ2), a high-capacity, low-affinity Ca2+-binding protein in the sarcoplasmic reticulum, have been associated with catecholamine-induced polymorphic ventricular tachycardia (CPVT). In order to understand the molecular mechanism and pathophysiological link between these CPVT-related missense mutations of hCSQ2 and the resulting arrhythmias, we generated three CPVT-causing mutants of hCSQ2 (R33Q, L167H, and D307H) and two non-pathological mutants (T66A and V76M) and investigated the effect of these mutations. In addition, we determined the crystal structure of the corresponding wild-type hCSQ2 to gain insight into the structural effects of those mutations. Our data show clearly that all three CPVT-related mutations lead to significant reduction in Ca2+-binding capacity in spite of the similarity of their secondary structures to that of the wild-type hCSQ2. Light-scattering experiments indicate that the Ca2+-dependent monomer-polymer transitions of the mutants are quite different, confirming that the linear polymerization behavior of CSQ is linked directly to its high-capacity Ca2+ binding. R33Q and D307H mutations result in a monomer that appears to be unable to form a properly oriented dimer. On the other hand, the L167H mutant has a disrupted hydrophobic core in domain II, resulting in high molecular aggregates, which cannot respond to Ca2+. Although one of the non-pathological mutants, T66A, shares characteristics with the wild-type, the other null mutant, V76M, shows significantly altered Ca2+-binding and polymerization behaviors, calling for careful reconsideration of its status.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. A diagram of CSQ polymerization. The CSQ molecule exists as either a monomer or a wide range of high molecular mass clusters, depending on the ionic environment. The extended N terminus of CSQ establishes the front-to-front dimer interface through arm exchange. Following a further increase of the concentration of Ca^2+, the carboxy terminus of CSQ, which is the most negative region, forms tetramer and higher-order linear polymers capturing substantial amounts of Ca^2+ in the back-to-back interface.
Figure 7.
Figure 7. Amino acid sequence comparison of human CSQ1 with human, canine, rabbit, chicken and xenopus CSQ2. Five mutational sites (R33, T66, V76, L167, and D307) are highlighted in green and the mutation was named according to the amino acid number in the unprocessed CSQ. The signal peptides are indicated with the black broken-line box. The secondary structural elements are indicated with colored arrows on top of the corresponding sequences and each domain (I, II and III) is marked with green lines.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2007, 373, 1047-1057) copyright 2007.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21118704 D.H.Maclennan, and E.Zvaritch (2011).
Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum.
  Biochim Biophys Acta, 1813, 948-964.  
20934451 D.W.Song, J.G.Lee, H.S.Youn, S.H.Eom, and d.o. .H.Kim (2011).
Ryanodine receptor assembly: a novel systems biology approach to 3D mapping.
  Prog Biophys Mol Biol, 105, 145-161.  
19920148 A.Kalyanasundaram, N.C.Bal, C.Franzini-Armstrong, B.C.Knollmann, and M.Periasamy (2010).
The calsequestrin mutation CASQ2D307H does not affect protein stability and targeting to the junctional sarcoplasmic reticulum but compromises its dynamic regulation of calcium buffering.
  J Biol Chem, 285, 3076-3083.  
19879546 M.Cerrone, C.Napolitano, and S.G.Priori (2009).
Catecholaminergic polymorphic ventricular tachycardia: A paradigm to understand mechanisms of arrhythmias associated to impaired Ca(2+) regulation.
  Heart Rhythm, 6, 1652-1659.  
  18347081 J.Qin, G.Valle, A.Nani, A.Nori, N.Rizzi, S.G.Priori, P.Volpe, and M.Fill (2008).
Luminal Ca2+ regulation of single cardiac ryanodine receptors: insights provided by calsequestrin and its mutants.
  J Gen Physiol, 131, 325-334.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer